--Chardan Trims Price Target on Achilles Therapeutics to $11 From $12, Keeps Buy Rating

--Chardan Trims Price Target on Achilles Therapeutics to $11 From $12, Keeps Buy Rating

MT Newswires · 05/11/2023 02:33

Please log in to view news